We are pleased to announce the opening of a siliconization line at our state-of-the-art Saint-Quentin Lamotte (SQLM) plant, which safeguards the integrity of sensitive, aggressive and viscous drug products.
What is siliconization?
SGD Pharma marked the start of the New Year by celebrating the renovation of its Saint-Quentin-Lamotte (SQLM) furnace No2 with a lighting ceremony performed by our appointed Godmother, Vanessa Rade, in accordance with glassmaking tradition.
SGD Pharma, Global market leader in molded glass primary packaging solutions for the pharmaceutical industry, announces the opening of a new siliconization operation at its state-of-the-art Saint-Quentin Lamotte (SQLM) plant.
Fabio Invernizzi is General Manager of SGD Pharma’s West BU. In his previous role as Vice-President and EMEA Business Unit Head of Capsules and Health Ingredients at Lonza, Fabio supervised sales of €450 million per annum.
SGD Pharma, der Weltmarktführer für Primärglasverpackungen, hat die Ernennung von Fabio Invernizzi zum neuen General Manager der BU West bekannt gegeben.
SGD Pharma gibt sein Ziel bekannt, Weltmarktführer für pharmazeutische Primärverpackungen aus Glas zu werden. CEO Olivier Rousseau erklärt, dass SGD Pharma bis 2024 ein deutliches Wachstum anstrebt, und zwar mit einem nachhaltigen und konsequenten Ansatz in den Bereichen Handel, Innovation, Industrie, Nachhaltigkeit, Personal und M&A.
